Harvard Apparatus Regenerative Technology, Inc.

About Harvard Apparatus Regenerative Technology, Inc.

HRGN is a clinical-stage biotechnology company focused on regenerating organ tissue damaged by cancer, trauma, birth defects, or other diseases using a patient's own stem cells grown on a hollow tubular scaffold.

Products & Services

Cellspan Esophageal Implant:A regenerative implant designed to treat esophageal damage or defects.

Therapeutic Solutions for Esophageal Atresia:Solutions addressing the life-threatening congenital defect of esophageal atresia, affecting approximately 1 in 4,000 babies in the US.

Specialties

Regenerative Medicine Stem Cell Technology Organ Tissue Regeneration Esophageal and Bronchial Implants

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Private Placement T: - FT: Private Placement	A: 5000000 MR: - FA: approximately $5 million FAN: 5000000	D: 2024-08-19 FD: 2024-08-19	1 investors

Private Placement Latest

2024-08-19

$5.0M

1 investor (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

S

Stephen F. Badylak

Chairman

C

Christine Finck

Executive Vice President, Surgeon-in-Chief and Peter Deckers Endowed Chair of Surgery

C

Charles S. Cox

George and Cynthia Mitchell Distinguished Chair in Neurosciences

J

Jerry He

CEO and Chairman of the Board

J

Jason Jing Chen

Vice Chairman

D

David Green

Director

View 13 more team members with Pro

Unlock Full Team Directory

Recent News